Search

Author/Creator Duyster, J.

1. A patient with refractory high-grade B-cell lymphoma and rapid progression under CAR-T-cell therapy was successfully salvaged with inotuzumab- ozogamicin. Issue 9 (29th July 2022)

Authors:
Strüßmann, T.; Wäsch, R.; Scherer, F.; Mutter, J. A.; Pfeifer, D.; Bartsch, I.; Giesler, S.; Graziani, G.; Duyster, J.; Finke, J.; Marks, R.
Journal:
Leukemia & lymphoma
Issue:
Volume 63:Issue 9(2022)
Page Start:
2260
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. NONINVASIVE DETECTION, CLASSIFICATION, AND RISK STRATIFICATION OF PRIMARY CNS LYMPHOMAS BY CTDNA PROFILING. (17th June 2021)

Authors:
Mutter, J. A.; Alig, S.; Lauer, E. M.; Esfahani, M. S.; Mitschke, J.; Kurtz, D. M.; Olsen, M.; Liu, C. L.; Jin, M. C.; Bleul, S.; Macaulay, C. W.; Neidert, N. N.; Heiland, D. H.; Finke, J.; Duyster, J.; Wehrle, J.; Prinz, M.; Illerhaus, G.; Reinacher, P. C.; Schorb, E.
Journal:
Hematological oncology
Issue:
Volume 39(2021)Supplement 2
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. S230: HUMAN ΒETA-DEFENSIN 2 TREATMENT MODULATES THE INTESTINAL MICROBIOME AND THE ALLOGENEIC T CELL RESPONSE TO LIMIT ACUTE GRAFT-VERSUS-HOST DISEASE. (23rd June 2022)

Authors:
Rückert, T.; Andrieux, G.; Boerries, M.; Woessner, N. M.; Minguet, S.; Doetsch, S.; Aumann, K.; Schiff, M; Braun, L. M.; Haring, E.; Siranosian, B. A.; Bhatt, A. S.; Nordkild, P.; Wehkamp, J.; Jensen, B. A. H.; Duyster, J.; Zeiser, R.; Köhler, N.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
131
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗